| Accession Number | 0001205703-26-000030 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 17, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, Global Head of R&D | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 2,957 | $61.76 | $182,624.32 | 186,157 | Direct | โ | View Details | |
President, Global Head of R&D | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 4,551 | $61.18 | $278,430.18 | 190,708 | Direct | โ | View Details | |
President, Global Head of R&D | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 6,477 | $64.25 | $416,147.25 | 197,185 | Direct | โ | View Details | |
President, Global Head of R&D | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 9,233 | $71.93 | $664,129.69 | 206,418 | Direct | โ | View Details | |
President, Global Head of R&D | Common Stock | โ | Sep 15, 2026 | Sale | 9,233 | $120.50 | $1,112,576.50 | 197,185 | Direct | โ | View Details | |
President, Global Head of R&D | Common Stock | โ | Sep 15, 2026 | Sale | 13,985 | $120.49 | $1,685,052.65 | 183,200 | Direct | โ | View Details | |
President, Global Head of R&D | Employee Stock Option (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 2,957 | $0.00 | $0.00 | 4,225 | Direct | โ | View Details | |
President, Global Head of R&D | Employee Stock Option (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 4,551 | $0.00 | $0.00 | 4,551 | Direct | โ | View Details | |
President, Global Head of R&D | Employee Stock Option (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 6,477 | $0.00 | $0.00 | 20,356 | Direct | โ | View Details | |
President, Global Head of R&D | Employee Stock Option (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 9,233 | $0.00 | $0.00 | 18,466 | Direct | โ | View Details |